Policy
-
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Policy Matters
Toward Improved Dosing in the Precision Oncology EraA forthcoming article series outlines considerations for the dose optimization of modern oncology drugs.
by Brad Davidson, PhD
-
Policy Matters
Progress in the Youth E-cigarette EpidemicNew data reveal a decrease in youth e-cigarette use but underscore the need for continued policy and advocacy efforts.
by Brad Davidson, PhD
-
Forward Look
Medicare Rule Expands Access to Navigation ServicesExperts hope Medicare reimbursement for patient navigation will allow more treatment sites to offer this assistance.
by Carolyn Bernhardt
-
Forward Look
The Cost of Dental Side EffectsHead and neck cancer survivors often face significant costs for treatments not covered by health insurance.
by Kris Conner
-
Policy Matters
The Future of Perioperative Clinical Trial DesignsA recent FDA-AACR workshop explored best practices for trial design, analysis and interpretation of clinical studies with multiple phases of treatment.
by Elizabeth M. Jaffee, MD
-
Policy Matters
Clinical Trial Endpoints for Timely Drug DevelopmentAs patients live longer with cancer, scientists need to rethink how to determine if a new drug is safe and effective.
by Kenneth Anderson, MD
-
Policy Matters
Cancer Research Funding Faces Uncertain FutureThe AACR is planning numerous initiatives in 2024 to bolster congressional support.
by Jon Retzlaff, MBA, MPA
-
Doctors Urge Need for ‘Common Sense Oncology’A movement of health care professionals say the toll of many cancer treatments is out of sync with the purported benefits.
by Kyle Bagenstose
-
Policy Matters
Taking Action to Support Cancer ResearchThe AACR releases AACR Cancer Progress Report 2023, announces Cancer Centers Alliance, and joins 11th Rally for Medical Research.
by Benjamin Krinsky, PhD
